Skip to main content
. Author manuscript; available in PMC: 2023 May 17.
Published in final edited form as: Circ Cardiovasc Imaging. 2023 May 9;16(5):e015089. doi: 10.1161/CIRCIMAGING.122.015089

Table 2.

Cardiac structure and function.

All (n=515) HFpEF (n=124) AF (n=193) HFpEF+AF (n=198) p value
LV EDD, mm 46 ± 5 46 ± 5 46 ±5 46 ± 5 0.59
LV ESD, mm 30 ± 4 30 ± 4 31 ± 4 31 ± 5 0.80
LV mass, g 177 ± 47 178 ± 49 177 ± 48 177 ± 46 0.97
LV mass index, g/h 2.7 43 ± 10 45 ± 12 42 ± 8 44 ± 11 0.03
LV hypertrophy 31 % 40 % 22 % 33 % 0.009
LV relative wall thickness 0.45 ± 0.09 0.45 ± 0.1 0.45 ± 0.08 0.46 ± 0.09 0.23
LV concentric geometry 57 % 58 % 54 % 59 % 0.63
LV EDV, ml 117 ± 35 124 ± 34 120 ± 36 110 ± 33 0.001
LV EF, % 65 ± 7 66 ± 7 65 ± 7 64 ± 8 0.03
LV GLS, % −17.3 ± 4.1 −19.0 ± 3.9* −16.7 ± 4.0 −16.9 ± 4.0 <0.001
Low GLS 50 % 32 % 55 % 57 % <0.001
LV GCS, % −26.8 ± 5.5 −28.4 ± 5.0 −25.5 ± 5.3* −27.0 ± 5.6 <0.001
Dilated right ventricle § 17 % 9 % 15 % 23 % 0.04
Right ventricular systolic dysfunction § 7 % 6 % 4 % 10 % 0.16
Mild/moderate tricuspid regurgitation 82 % 74 % 83 % 83 % <0.001
Estimated SPAP, mmHg 45 ± 13 49 ± 16 41 ± 9 46 ± 13 <0.001

Values are mean ± standard deviation or percentage. The p value in the last table column indicates the statistical significance when testing the overall group differences (by ANOVA for continuous variables and chi-square or Fisheŕs exact test for categorical variables).

*

p < 0.05 vs. all the other groups by Sidaks′ posthoc test.

p < 0.05 vs. the HFpEF group by Sidaks′ posthoc test.

p < 0.05 vs. the AF group by Sidaks′ posthoc test.

§

Based on qualitative assessment.

AF = atrial fibrillation; EDD = end-diastolic diameter; EDV = end-diastolic volume; EF = ejection fraction; ESD = end-systolic diameter; GCS = global circumferential strain; GLS = global longitudinal strain; HFpEF = heart failure with preserved ejection fraction; LV = left ventricular; SPAP = systolic pulmonary artery pressure.